- Home
- XERS vs VET Comparison
XERS vs VET Comparison
Compare XERS & VET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | XERS | VET |
|---|---|---|
| Founded | 2005 | 1994 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Oil & Gas Production |
| Sector | Health Care | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.2B | 1.3B |
| IPO Year | 2018 | N/A |
Fundamental Metrics
Financial Performance| Metric | XERS | VET |
|---|---|---|
| Price | $7.92 | $8.26 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 7 | 0 |
| Target Price | ★ $10.43 | N/A |
| AVG Volume (30 Days) | ★ 2.5M | 1.4M |
| Earning Date | 11-06-2025 | 11-05-2025 |
| Dividend Yield | N/A | ★ 4.60% |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $266,137,000.00 | ★ $1,445,514,003.00 |
| Revenue This Year | $44.37 | $11.40 |
| Revenue Next Year | $27.87 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 42.05 | 30.48 |
| 52 Week Low | $3.14 | $5.14 |
| 52 Week High | $10.08 | $10.49 |
Technical Indicators
Market Signals| Indicator | XERS | VET |
|---|---|---|
| Relative Strength Index (RSI) | 59.42 | 48.46 |
| Support Level | $6.88 | $7.76 |
| Resistance Level | $8.42 | $8.64 |
| Average True Range (ATR) | 0.43 | 0.25 |
| MACD | 0.10 | -0.01 |
| Stochastic Oscillator | 70.38 | 57.06 |
Price Performance
Historical ComparisonAbout XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offer Recorlev for the treatment of Cushing's syndrome, Gvoke for the treatment of severe hypoglycemia, and Keveyis for the treatment of Primary Periodic Paralysis (PPP).
About VET Vermilion Energy Inc.
Vermilion Energy Inc is an international oil and gas-producing company. The company engages in full-cycle exploration and production programs that focus on the acquisition, exploration, development, and optimization of producing properties in North America, Europe, and Australia. The majority of Vermilion's revenue is derived from the production and sale of petroleum and natural gas. In each market, the company relies on a host of drilling and well-completion techniques to keep production at attractive levels. Geographically, the company derives majority of its revenue from Canada.